Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi011-A) from a patient with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutation

We used a non-integrated reprogramming approach to establish a human induced pluripotent stem cell (hiPSC) line (INNDSUi011-A) from the skin fibroblasts of a 38-year-old female individual with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutation. The cells obtained demonstrate key chara...

Full description

Saved in:
Bibliographic Details
Main Authors: Didi Shan, Hongxu Wang, Jianing Li, Yu Wang, Fuchen Liu
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506125001576
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849228389431377920
author Didi Shan
Hongxu Wang
Jianing Li
Yu Wang
Fuchen Liu
author_facet Didi Shan
Hongxu Wang
Jianing Li
Yu Wang
Fuchen Liu
author_sort Didi Shan
collection DOAJ
description We used a non-integrated reprogramming approach to establish a human induced pluripotent stem cell (hiPSC) line (INNDSUi011-A) from the skin fibroblasts of a 38-year-old female individual with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutation. The cells obtained demonstrate key characteristics of embryonic stem cells, including the expression of specific pluripotency markers and the capacity to differentiate into the three germ layers in vitro. This iPSC cell line retains the patient’s genetic information, making it a valuable model for studying disease mechanisms and developing novel therapies.
format Article
id doaj-art-b1cce69693d14ac887bfdd32d77ea121
institution Kabale University
issn 1873-5061
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series Stem Cell Research
spelling doaj-art-b1cce69693d14ac887bfdd32d77ea1212025-08-23T04:47:57ZengElsevierStem Cell Research1873-50612025-09-018710380710.1016/j.scr.2025.103807Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi011-A) from a patient with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutationDidi Shan0Hongxu Wang1Jianing Li2Yu Wang3Fuchen Liu4Department of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Jinan 250012 Shandong, ChinaDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Jinan 250012 Shandong, ChinaDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Jinan 250012 Shandong, ChinaPrenatal Diagnostic Center of Obstetrics and Department of Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, ChinaDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Jinan 250012 Shandong, China; Corresponding author.We used a non-integrated reprogramming approach to establish a human induced pluripotent stem cell (hiPSC) line (INNDSUi011-A) from the skin fibroblasts of a 38-year-old female individual with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutation. The cells obtained demonstrate key characteristics of embryonic stem cells, including the expression of specific pluripotency markers and the capacity to differentiate into the three germ layers in vitro. This iPSC cell line retains the patient’s genetic information, making it a valuable model for studying disease mechanisms and developing novel therapies.http://www.sciencedirect.com/science/article/pii/S1873506125001576
spellingShingle Didi Shan
Hongxu Wang
Jianing Li
Yu Wang
Fuchen Liu
Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi011-A) from a patient with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutation
Stem Cell Research
title Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi011-A) from a patient with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutation
title_full Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi011-A) from a patient with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutation
title_fullStr Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi011-A) from a patient with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutation
title_full_unstemmed Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi011-A) from a patient with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutation
title_short Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi011-A) from a patient with autosomal dominant spastic paraplegia 9A due to ALDH18A1 mutation
title_sort establishment of an induced pluripotent stem cell ipsc line inndsui011 a from a patient with autosomal dominant spastic paraplegia 9a due to aldh18a1 mutation
url http://www.sciencedirect.com/science/article/pii/S1873506125001576
work_keys_str_mv AT didishan establishmentofaninducedpluripotentstemcellipsclineinndsui011afromapatientwithautosomaldominantspasticparaplegia9aduetoaldh18a1mutation
AT hongxuwang establishmentofaninducedpluripotentstemcellipsclineinndsui011afromapatientwithautosomaldominantspasticparaplegia9aduetoaldh18a1mutation
AT jianingli establishmentofaninducedpluripotentstemcellipsclineinndsui011afromapatientwithautosomaldominantspasticparaplegia9aduetoaldh18a1mutation
AT yuwang establishmentofaninducedpluripotentstemcellipsclineinndsui011afromapatientwithautosomaldominantspasticparaplegia9aduetoaldh18a1mutation
AT fuchenliu establishmentofaninducedpluripotentstemcellipsclineinndsui011afromapatientwithautosomaldominantspasticparaplegia9aduetoaldh18a1mutation